We are live on ! Find out more
VIVS

VivoSim Labs
VIVS

115 hedge funds and large institutions have $66.1M invested in VivoSim Labs in 2016 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 35 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

71% more capital invested

Capital invested by funds: $38.6M → $66.1M (+$27.5M)

6% more funds holding

Funds holding: 109 → 115 (+6)

0% less ownership

Funds ownership: 0.08% → 0.08% (-0%)

29% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 35

76% less call options, than puts

Call options by funds: $1.52M | Put options by funds: $6.23M

Holders
115
Holders Change
+6
Holders Change %
+5.5%
% of All Funds
3.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
25
Reduced
35
Closed
8
Calls
$1.52M
Puts
$6.23M
Net Calls
-$4.71M
Net Calls Change
-$3.23M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$786K
2
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$740K
3
PM
Penbrook Management
New York
+$196K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$190K
5
ARTA
A.R.T. Advisors
New York
+$174K

Top Sellers

Rank Fund Capital Flow
1
LPL Financial
LPL Financial
California
-$307K
2
BFA
BlackRock Fund Advisors
California
-$291K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$272K
4
Morgan Stanley
Morgan Stanley
New York
-$241K
5
VKH
Virtu KCG Holdings
New York
-$226K

VIVS Hedge Fund Activity: Q2 2016 in Review

115 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2016, worth a combined $66.1M — up 71% from $38.6M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new VIVS positions and 8 closed out — a net gain of 8 holders — while 25 added to existing stakes and 35 trimmed.

The largest buyer was Vanguard Group, adding an estimated $786K. The largest seller was LPL Financial, cutting an estimated $307K.

  • 115 institutional investors held VivoSim Labs (VIVS) as of Q2 2016, up from 109 in Q1 2016.
  • Funds reported $66.1M of VivoSim Labs stock for Q2 2016, up 71% quarter-over-quarter.
  • 16 funds opened new VivoSim Labs positions in Q2 2016 and 8 closed out, a net change of +8 holders.
  • The largest VivoSim Labs buyer in Q2 2016 was Vanguard Group, an estimated $786K added.
  • The largest VivoSim Labs seller in Q2 2016 was LPL Financial, an estimated $307K sold.

Based on aggregated 13F filings for Q2 2016.